These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 19089912)

  • 1. Activator protein 2 alpha (AP2alpha) suppresses 42 kDa C/CAAT enhancer binding protein alpha (p42(C/EBPalpha)) in head and neck squamous cell carcinoma.
    Bennett KL; Romigh T; Arab K; Teresi RE; Tada Y; Eng C; Plass C
    Int J Cancer; 2009 Mar; 124(6):1285-92. PubMed ID: 19089912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor suppressor activity of CCAAT/enhancer binding protein alpha is epigenetically down-regulated in head and neck squamous cell carcinoma.
    Bennett KL; Hackanson B; Smith LT; Morrison CD; Lang JC; Schuller DE; Weber F; Eng C; Plass C
    Cancer Res; 2007 May; 67(10):4657-64. PubMed ID: 17510391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C/EBP transcription factors in human squamous cell carcinoma: selective changes in expression of isoforms correlate with the neoplastic state.
    Anand S; Ebner J; Warren CB; Raam MS; Piliang M; Billings SD; Maytin EV
    PLoS One; 2014; 9(11):e112073. PubMed ID: 25402211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-regulation of the expression of CCAAT/enhancer binding protein α gene in cervical squamous cell carcinoma.
    Pan Z; Zheng W; Zhang J; Gao R; Li D; Guo X; Han H; Li F; Qu S; Shao R
    BMC Cancer; 2014 Jun; 14():417. PubMed ID: 24913332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer.
    Tada Y; Brena RM; Hackanson B; Morrison C; Otterson GA; Plass C
    J Natl Cancer Inst; 2006 Mar; 98(6):396-406. PubMed ID: 16537832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AP-2alpha induces epigenetic silencing of tumor suppressive genes and microsatellite instability in head and neck squamous cell carcinoma.
    Bennett KL; Romigh T; Eng C
    PLoS One; 2009 Sep; 4(9):e6931. PubMed ID: 19742317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of the CCAAT/enhancer-binding proteins C/EBPalpha, C/EBPbeta and C/EBPdelta in breast cancer: correlations with clinicopathologic parameters and cell-cycle regulatory proteins.
    Milde-Langosch K; Löning T; Bamberger AM
    Breast Cancer Res Treat; 2003 May; 79(2):175-85. PubMed ID: 12825852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of the transcriptional repressor Gfi-1 is regulated by C/EBP{alpha} and is involved in its proliferation and colony formation-inhibitory effects in p210BCR/ABL-expressing cells.
    Lidonnici MR; Audia A; Soliera AR; Prisco M; Ferrari-Amorotti G; Waldron T; Donato N; Zhang Y; Martinez RV; Holyoake TL; Calabretta B
    Cancer Res; 2010 Oct; 70(20):7949-59. PubMed ID: 20924107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CCAAT/enhancer-binding protein-alpha is induced during the early stages of Kaposi's sarcoma-associated herpesvirus (KSHV) lytic cycle reactivation and together with the KSHV replication and transcription activator (RTA) cooperatively stimulates the viral RTA, MTA, and PAN promoters.
    Wang SE; Wu FY; Yu Y; Hayward GS
    J Virol; 2003 Sep; 77(17):9590-612. PubMed ID: 12915572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a co-repressor that inhibits the transcriptional and growth-arrest activities of CCAAT/enhancer-binding protein alpha.
    McFie PJ; Wang GL; Timchenko NA; Wilson HL; Hu X; Roesler WJ
    J Biol Chem; 2006 Jun; 281(26):18069-80. PubMed ID: 16644732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diminished expression of C/EBPalpha in skin carcinomas is linked to oncogenic Ras and reexpression of C/EBPalpha in carcinoma cells inhibits proliferation.
    Shim M; Powers KL; Ewing SJ; Zhu S; Smart RC
    Cancer Res; 2005 Feb; 65(3):861-7. PubMed ID: 15705884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p300 coactivates the adipogenic transcription factor CCAAT/enhancer-binding protein alpha.
    Erickson RL; Hemati N; Ross SE; MacDougald OA
    J Biol Chem; 2001 May; 276(19):16348-55. PubMed ID: 11340085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CCAAT/enhancer binding protein alpha binds to the Epstein-Barr virus (EBV) ZTA protein through oligomeric interactions and contributes to cooperative transcriptional activation of the ZTA promoter through direct binding to the ZII and ZIIIB motifs during induction of the EBV lytic cycle.
    Wu FY; Wang SE; Chen H; Wang L; Hayward SD; Hayward GS
    J Virol; 2004 May; 78(9):4847-65. PubMed ID: 15078966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequential repression and activation of the CCAAT enhancer-binding protein-alpha (C/EBPalpha ) gene during adipogenesis.
    Jiang MS; Lane MD
    Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12519-23. PubMed ID: 11050170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CCAAT-enhancer binding protein-α (C/EBPα) and hepatocyte nuclear factor 4α (HNF4α) regulate expression of the human fructose-1,6-bisphosphatase 1 (FBP1) gene in human hepatocellular carcinoma HepG2 cells.
    Wattanavanitchakorn S; Rojvirat P; Chavalit T; MacDonald MJ; Jitrapakdee S
    PLoS One; 2018; 13(3):e0194252. PubMed ID: 29566023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of age on the posttranscriptional regulation of CCAAT/enhancer binding protein alpha and CCAAT/enhancer binding protein beta isoform synthesis in control and LPS-treated livers.
    Hsieh CC; Xiong W; Xie Q; Rabek JP; Scott SG; An MR; Reisner PD; Kuninger DT; Papaconstantinou J
    Mol Biol Cell; 1998 Jun; 9(6):1479-94. PubMed ID: 9614188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the Xenopus laevis CCAAT-enhancer binding protein alpha gene promoter demonstrates species-specific differences in the mechanisms for both auto-activation and regulation by Sp1.
    Kockar FT; Foka P; Hughes TR; Kousteni S; Ramji DP
    Nucleic Acids Res; 2001 Jan; 29(2):362-72. PubMed ID: 11139605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C/EBPα inhibits hepatocellular carcinoma by reducing Notch3/Hes1/p27 cascades.
    Shi YC; Zhao H; Yin C; Zeng X; Zhang Q; Xu WP; Wei J; Chen F; Xie WF
    Dig Liver Dis; 2013 Oct; 45(10):844-51. PubMed ID: 23816696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The CCAAT enhancer-binding protein alpha (C/EBPalpha) requires a SWI/SNF complex for proliferation arrest.
    Müller C; Calkhoven CF; Sha X; Leutz A
    J Biol Chem; 2004 Feb; 279(8):7353-8. PubMed ID: 14660596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Constitutive activation of transcription factors NF-(kappa)B, AP-1, and NF-IL6 in human head and neck squamous cell carcinoma cell lines that express pro-inflammatory and pro-angiogenic cytokines.
    Ondrey FG; Dong G; Sunwoo J; Chen Z; Wolf JS; Crowl-Bancroft CV; Mukaida N; Van Waes C
    Mol Carcinog; 1999 Oct; 26(2):119-29. PubMed ID: 10506755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.